This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Der französische Pharmagigant Sanofi will das Geschäft mit rezeptfreien Medikamenten an einen amerikanischen Finanzinvestor verkaufen. Zu dem Paket gehört auch das beliebteste Schmerzmittel des ...

Die Sanofi Dividende wird für das vergangene Geschäftsjahr auf der aktuellen Hauptversammlung von Sanofi festgelegt. Der Vorstand von Sanofi macht dabei zunächst einen Vorschlag für die Sanofi ...

Sanofi's rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused on developing a new generation of safer antibody-based therapies.

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 11,687.23 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...

While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that having MNC stocks in your portfolio is an assurance of growth ...